884
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Study on patients with Clostridioides difficile infection during the COVID-19 pandemic in Bulgaria

ORCID Icon, , , , , , , , & show all
Pages 188-193 | Received 03 Oct 2022, Accepted 11 Jan 2023, Published online: 28 Jan 2023

References

  • Atzrodt CL, Maknojia I, McCarthy RDP, et al. A guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2. FEBS J. 2020;287(17):3633–3650.
  • Habas K, Nganwuchu C, Shahzad F, et al. Resolution of coronavirus disease 2019 (COVID-19). Expert Rev anti Infect Ther. 2020;18(12):1201–1211.
  • Laura Linares-García L, Cárdenas-Barragán E, Hernández-Ceballos W, et al. Bacterial and fungal gut dysbiosis and Clostridium difficile in COVID-19: a review. J Clin Gastroenterol. 2022;56(4):285–298.
  • Megyeri K, Dernovics Á, Al-Luhaibi ZII, et al. COVID-19-associated diarrhea. World J Gastroenterol. 2021;27(23):3208–3222.
  • Kola A, Wiuff C, Akerlund T, et al. Survey of Clostridium difficile infection surveillance systems in Europe. Euro Surveill. 2011;21(29):30291.
  • Crobach MJT, Planche T, Eckert C, et al. European Society of clinical microbiology and infectious diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2016;22(s4):s63–s81.
  • Bentivegna Е, Alessio G, Spuntarelli V, et al. Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection. Am J Infect Control. 2021;49(5):640–642.
  • Manea E, Jipa R, Milea A, et al. Healthcare-associated Clostridioides difficile infection during the COVID-19 pandemic in a tertiary care hospital in Romania. Rom J Intern Med. 2021;59(4):409–415.
  • McDonald LC, Gerding D, Stuart Johnson S, et al. Clinical Practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1–e48.
  • Chedid M, Waked R, Haddad E, et al. Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy. J Infect Public Health. 2021;14(5):570–576.
  • Kariyawasam JC, Jayarajah U, Riza R, et al. Gastrointestinal manifestations in COVID-19. Trans R Soc Trop Med Hyg. 2021;115(12):1362–1388.
  • Lei HY, Ding YH, Nie K, et al. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. Biomed Pharmacother. 2021;133:111064.
  • Khanna S, Kraft CS. The interplay of SARS-CoV-2 and Clostridioides difficile infection. Future Microbiol. 2021;16:439–443.
  • Townsend N, Kazakiewicz D, Lucy Wright F, et al. Epidemiology of cardiovascular disease in Europe. Nat Rev Cardiol. 2022;19(2):133–143.
  • Eurostat. Heart diseases and strokes cause over 1.8 million deaths in the EU [Internet]; 2017. Available at: https://ec.europa.eu/eurostat/web/products-eurostat-news/-/edn-20170928-1.
  • Atanasova E, Mircheva I, Dokova K. Regional disparities in all-cause mortality in Bulgaria for the period 2000–2012. Scr Sci Salut Publicae. 2016;2(1):7–11.
  • Schäffler H, Breitrück A. Clostridium difficile - from colonization to infection. Front Microbiol. 2018;9:646.
  • Minni A, Ralli M, Candelori F, et al. Lessons learned from COVID-19 pandemic in Italy - a commentary. Bosn J Basic Med Sci. 2021;21(1):117–119.
  • Bartoli A, Gabrielli F, Alicandro T, et al. COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs. Intern Emerg Med. 2021;16(2):281–308.
  • Denson JL, Gillet AS, Zu Y, Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group, et al. Metabolic Syndrome and acute respiratory distress syndrome in hospitalized patients with COVID-19. JAMA Netw Open. 2021;4(12):e2140568.
  • European Centre for Disease Prevention and Control. European Surveillance of Clostridium difficile infections. Surveillance protocol version 2.2. Stockholm: ECDC; 2015.
  • van Prehn J, Reigadas E, Vogelzang EH, Guideline Committee of the European Study Group on Clostridioides difficile, et al. European Society of clinical microbiology and infectious diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect. 2021;27(Suppl 2):S1–S21.
  • Spigaglia P. Clostridioides difficile infection in the COVID-19 era: old and new problems. Pol Arch Intern Med. 2021;131(2):118–120.
  • Cammarota G, Giambò F, Ianiro G. Clostridioides difficile infection during the COVID-19 pandemic: a gut microbiota–based relationship. Pol Arch Intern Med. 2021;131(2):116–117.